肾功能不全血管钙化的机制
被引量:4
Mechanism of Vascular Calcification in Renal Dysfunction
摘要
既往认为血管钙化是钙磷在血管壁的被动的沉积过程,近年细胞生物学和血管影像学的研究表明血管钙化是与骨生成相似的高度可调控的过程。多种机制参与了血管钙化的发生发展。其中磷,甲状旁腺素相关肽,维生素D,骨调节蛋白,脂质紊乱和炎症等在血管钙化中的发生发展中具有重要的调节作用。
出处
《中国分子心脏病学杂志》
CAS
2005年第5期753-757,共5页
Molecular Cardiology of China
参考文献20
-
1薛骏,杨海春,李铭新,陆福明,顾勇,林善锬.炎症在尿毒症血管病变中的作用及其机制[J].中华肾脏病杂志,2001,17(6):404-407. 被引量:27
-
2[2]Moe SM, O'Neill KD, Duan D et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins.Kidney Int, 2002, 61 : 638-647.
-
3[3]Ahmed S, Kalisha D, Antoinette F, et al. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis, 2001,37: 1267-1276.
-
4[4]Jone S, Mckee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000,87 (7): 10-17.
-
5[5]Jono S, Nishizawa Y, Shioi A, et al. Parathyroid hormone-related peptide as a local regulator of vascular calcification its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells.Arterioscler Thromb Vasc Biol , 1997,17:1135-1142.
-
6[6]Huang Z, Li J, Jiang Z, et al. Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol, 2003 Jul,42( 1 ) :89-97.
-
7[7]Jono S, Nishizawa Y, Shioi A, et al. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation, 1998,98:1302-1306 .
-
8[8]Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix gla protein. Nature, 1997,386: 78-81.
-
9[9]Schurgers LJ, Soute BA, Vermeer C. Undercarboxylated matrix glaprotein is associated with vascular calcification. American Heart Association, Inc. 2004, 24 (5): e22.
-
10[10]Goodman WG. Vascular calcification in chronic renal failure. Lancet, 2001,358:1115-1116.
二级参考文献9
-
1Bergstrom J,Lindholm B.Malnutrition, cardiac disease and mortality: An integrated point of view[].American Journal of Kidney Diseases.1998
-
2Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men[].New England Journal of Homeopathy.1997
-
3Whicher J,Biasucci L,Rifai N.Inflammation, the acute phase response and atherosclerosis[].Clinical Chemistry and Laboratory Medicine.1999
-
4Panichi V,Migliori M,De Pietro S,et al.C-reactive protein as a marker of chronic inflammation in uremic patients[].Blood Purification.2000
-
5Zimmermann J,Herrlinger S,Pruy A,et al.Inflammation enhances cardiovascular risk and mortality in hemodialysis patients[].Kidney International.1999
-
6Stenvinkel P,Heimburger O,Paultre F,et al.Strong association between malnutrition, inflammation and athersclerosis in chronic renal failure[].Kidney International.1999
-
7Kunsch C,Medford RM.Oxidative stress as a regulator of gene expression in the vasculature[].Circulation Research.1999
-
8Johnson AM.Low levels of plasma protein: malnutrition or inflammation[].Clinical Chemistry and Laboratory Medicine.1999
-
9Stenvinkel P,Heimburger O,Lindholm B,et al.Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)[].Nephrology Dialysis Transplantation.2000
共引文献26
-
1张秀荣.维持性血液透析患者C-反应蛋白与其营养不良、贫血的关系[J].中国实用医药,2006,1(2). 被引量:2
-
2龚蓉,张玲.尿毒症血液透析患者C反应蛋白改变及相关临床意义[J].中国血液净化,2002,1(12):22-23. 被引量:3
-
3高潮清,朱桂岚.慢性肾衰竭急剧加重危险因素分析[J].实用全科医学,2004,2(6):479-480. 被引量:15
-
4张爱华,梁力均,朱宁,阿拉塔,范敏华.血液透析对维持性血透患者体内氧化应激和一氧化氮水平的影响[J].中国医师杂志,2004,6(12):1631-1633. 被引量:4
-
5王美芬,周绍玲.尿毒症毒素对心血管系统的影响[J].青岛医药卫生,2005,37(2):121-122.
-
6管红斌,黄华,桓文穆.血液透析患者C-反应蛋白与贫血、营养不良及感染的关系[J].广州医药,2005,36(5):14-16.
-
7王四清.尿毒症合并胸主动脉夹层分离1例[J].福建医药杂志,2005,27(4):191-192.
-
8管红斌,吕路,黄华,桓文穆.尿毒病血液透析患者C-反应蛋白与贫血、营养不良及感染的关系[J].中国血液净化,2005,4(11):632-633. 被引量:4
-
9邵建华,薛骏,李铭新,杨海春,丁峰,陆福明,顾勇,林善锬.尿毒症患者桡动脉上炎症因子表达和氧化脂质沉积对内瘘寿命影响的COX分析[J].中华肾脏病杂志,2006,22(12):743-746. 被引量:5
-
10李立,王笑云,刘殿阁,刘必成,高民.维持性血液透析患者微炎症状态与血管通路失功的相关研究[J].中国血液净化,2007,6(10):538-542. 被引量:40
同被引文献66
-
1张超,胡昭,董帅.终末期肾病维持性血液透析患者生存率和死亡的影响因素[J].中国老年学杂志,2014,34(5):1241-1243. 被引量:59
-
2Cohn JN,Duprez DA,Grandits GA.Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment[J].Hypertension,2005,46(1):217-220.
-
3Stephanie S,DeLoach,Raymond R,et al.Vascular stiffness:its measurement and significance for epidemiologic and outcome studies[J].Clinical Journal of the American Society of Nephrology,2008,3(1):184-192.
-
4Adeney KL,Siscovick DS,Ix JH,et al.Association of serum phosphate with vascular and valvular calcification in moderate CKD[J].Journal of theAmericanSocietyof Nephrology,2009,20(2):381-387.
-
5Moe SM,Chen NX.Inflammation and vascularcalcification[J].Blood Purification,2005,23(1):64-71.
-
6Moe SM,Chen NX.Pathophysiology of calcification in chronic kidney disease[J].Circulation Research,2004,95(6):560-567.
-
7Glachelli CM.Vascular calcification machanisms[J].Journal of the American Society of Nephrology,2004,15(12):2959-2964.
-
8Schoming M,Eisenhandt A,Ritz E.The microinflammatorystate of uremia[J].Blood Purification,2000,18(4):327-332.
-
9Kaysen GA.The microinflammatory state in uremia:cause andpotential consequences[J].Journal of theAmerican Society of Nephrology,2001,12(7):1549-1557.
-
10Bostro K.Proinflammatory vascular calcification[J].Circulation Research,2005,96(12):1219-1220.
引证文献4
-
1周进,陈明.骨形成蛋白与终末期肾脏病患者的血管钙化[J].医学综述,2008,14(4):510-512. 被引量:3
-
2范旗,赵燕凌,甘西伦.慢性肾脏病患者血清PTH与BMP-2的变化及意义[J].山东医药,2008,48(28):74-75.
-
3闫铁昆.终末期肾病患者炎性因子与血管钙化研究进展[J].透析与人工器官,2010,21(1):18-22. 被引量:7
-
4曾湘杰,邹东媚,李亦舒,曾梅珍.参附注射液对维持性血液透析患者心率变异性及炎性因子的影响分析[J].中国医药科学,2020,10(3):234-237. 被引量:4
二级引证文献13
-
1饶飞平,尧佩.连续缓慢短期血液透析疗法治疗终末期肾病浮肿的效果[J].透析与人工器官,2023,34(1):30-33.
-
2王婷婷,刘中柱.不同血液净化方式对维持性血液透析患者微炎症状态的影响[J].世界最新医学信息文摘,2020(6):99-100. 被引量:2
-
3闫铁昆.终末期肾病患者炎性因子与血管钙化研究进展[J].透析与人工器官,2010,21(1):18-22. 被引量:7
-
4焦春红,姜埃利.对终末期肾脏病血管钙化的再认识[J].国际移植与血液净化杂志,2012,10(3):4-8. 被引量:5
-
5刘玺,沈明静,缪蕙,刘芳,胡明亮.终末期肾病患者行甲状旁腺切除对颈动脉钙化的影响[J].现代生物医学进展,2012,12(24):4711-4713.
-
6郭帅,徐金升,王悦芬,白亚玲,张俊霞,崔立文,张胜雷.高磷对大鼠胸主动脉血管环中骨形成蛋白2表达的影响[J].临床心血管病杂志,2017,33(1):74-79.
-
7唐特.β2-微球蛋白与C-反应蛋白对Ⅳ型心肾综合征诊断及预后的判断意义[J].上海医药,2018,39(7):49-52. 被引量:4
-
8朱雪娟,孙静.不同血液净化方式对老年终末期肾脏病患者IL-6、TNF-α、hs- CRP、白蛋白和前白蛋白水平的影响[J].中国老年学杂志,2019,39(10):2423-2425. 被引量:19
-
9陈雨,李旻,周华,杨敏,孙军.维持性血液透析患者血清IGF-1、SOST与血管钙化的关系[J].山东医药,2020,60(25):85-88. 被引量:11
-
10朱岩,陈民.中医延伸护理联合苦参复律汤治疗功能性早搏和心率变异性的临床效果[J].中国医药导报,2020,17(25):160-163.
-
1周业波,陆峥飞,齐永芬.糖尿病与血管钙化[J].中国动脉硬化杂志,2009,17(3):241-245. 被引量:7
-
2袁自宏,周健美.终末期肾病患者的血管钙化与骨调节蛋白[J].实用药物与临床,2007,10(5):298-300.
-
3史雨晨,柳景华.血管钙化:从基础研究到临床应用[J].中华医学杂志,2015,95(40):3317-3320. 被引量:5
-
4王少岩,朱巧,衣兰娟.血塞通对急性冠脉综合征C-反应蛋白水平的影响[J].医学综述,2007,13(8):637-637. 被引量:2
-
5尹宁,梁静.Hs-CRP联合血脂检测对冠心病的预测价值[J].新疆医学,2006,36(4):103-105. 被引量:1
-
6曾华松,刘绪青.肾脏病脂质紊乱发生机制研究进展[J].临床荟萃,1997,12(12):530-532.
-
7曾华松.肾脏病脂质紊乱研究进展[J].医学新知,1996,6(3):141-143.
-
8滕兰波(综述),赵久阳(审校).慢性肾衰竭患者血管钙化机制的研究进展[J].国际泌尿系统杂志,2007,27(2):248-252.
-
9时惠,周晓辉.骨质疏松症与老年钙化性瓣膜病相关性认识[J].医学综述,2014,20(11):1994-1996. 被引量:1
-
10刘素雁,孙正达,金晓明,王晓霞.红细胞生成素对慢性肾功能衰竭大鼠脂质紊乱的作用[J].中华肾脏病杂志,2001,17(3):194-195. 被引量:9